Efficacy And Safety of Glimpride in Type 2 Diabetes Patients in Eastern Libya
Derna Universiry Journal of Medical Sciences · 30.12.2024 · 2 (2) · 150-160
DOI: 10.58987/1zte5k85 ↗Kurz gefasst
Fachartikel in der Zeitschrift Derna Universiry Journal of Medical Sciences, online erschienen am 30.12.2024. Verfasst von Amal M Mohammed und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Glimepiride is a drug used in the treatment of type 2 diabetes and can be combined with metformin, another anti-hyperglycemic agent, for patients with difficulty controlling their blood sugar levels. Study Timeframe: This study was conducted during 2023–2024. The study consisted of two parts, the first of which includes the theoretical computer framework, which dealt with the advanced study of some information related to the subject of the study, and the second is the procedural aspect or computer construction, in which the study group used a study form to fill in the data, and then it was statistically analyzed and its results were commented on. The spatial boundaries were represented in the outpatient clinics of the National Center for Diabetes and Endocrinology, eastern Libya (Al-marj – Benghazi – Al-Abyar). The sample consisted of 150 patients with type 2 diabetes (56 males – 94 females), aged between 32–90 years, selected based on initial hemoglobin and fasting plasma glucose measurements. Most received Glimepiride in combination with Metformin. The study concluded that Glimepiride is safe with no observed side effects and improved blood sugar control in patients, as well as hemoglobin and fasting plasma glucose levels.
Zitieren
APA
Mohammed, A. M., Mohammed, B. S., & Saed, H. S. (2024). Efficacy And Safety of Glimpride in Type 2 Diabetes Patients in Eastern Libya. Derna Universiry Journal of Medical Sciences, 2(2), 150-160. https://doi.org/10.58987/1zte5k85
Vancouver
Mohammed AM, Mohammed BS, Saed HS. Efficacy And Safety of Glimpride in Type 2 Diabetes Patients in Eastern Libya. Derna Universiry Journal of Medical Sciences. 2024;2(2):150-160. doi:10.58987/1zte5k85
BibTeX
@article{Mohammed2024,
author = {Mohammed, Amal M and Mohammed, Bushra Saleh and Saed, Hibahtallah Saeid},
title = {Efficacy And Safety of Glimpride in Type 2 Diabetes Patients in Eastern Libya},
journal = {Derna Universiry Journal of Medical Sciences},
year = {2024},
volume = {2},
number = {2},
pages = {150--160},
doi = {10.58987/1zte5k85}
}
EUVIMED